Table 5.
Market share of the alternative treatments
Comparators | Market share in units (%) | Source |
Paliperidone ER | 0.0 | Not yet marketed |
Risperidone | 42.0 | http://www.imshealth.com |
Olanzapine | 34.4 | http://www.imshealth.com |
Quetiapine | 14.1 | http://www.imshealth.com |
Ziprasidone | 4.7 | http://www.imshealth.com |
Aripiprazole | 4.8 | http://www.imshealth.com |